Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Why brain-based GLP-1 activity matters clinically: It helps explain the appetite-suppressing effects of GLP-1 receptor agonist medications It may contribute to neuroprotective mechanisms being investigated in neurodegenerative diseases It potentially influences cognitive processes and mood regulation, though human evidence remains limited It provides insight into the gut-brain axis and metabolic-neurological interactions Understanding GLP-1's cerebral actions has become particularly relevant as GLP-1 receptor agonistsoriginally developed for type 2 diabetesare now also licensed for weight management in the UK (NICE TA875, TA664)
By this dual approach, it amplifies the benefits seen with GLP-1 agonists by targeting both incretin pathways (Rizvi and Rizzo 2022)
A single compound addresses skin aging, hair loss, wound healing, and systemic inflammation through well-documented molecular pathways
It shall not be misbranded, mislabeled or misused as such
